In conclusion, our data provide strong evidence for H19-mediated APOBEC3G expression, which in turn activates TGF-β/Smad2 signaling and thereby contributes to the progression of pancreatic cancer, and this process is inhibited by sulforaphane. Here, APOBEC3G is linked to pancreatic neoplasm.